newsfilter
← Latest News
GlobeNewswire·

4DMT Provides Company Update and Anticipated Development Milestones for 2026

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as of January 6,